Semax 10mg

Semax is a synthetic heptapeptide (ACTH(4–10)-derived analogue) used in controlled in-vitro studies of neuropeptide signalling, receptor-adjacent pathways, and structure–activity relationships under non-clinical laboratory conditions.

Semax — 10 mg | Research Use Only

This listing provides a 10 mg vial as a lyophilised solid for cell-based and biochemical model systems. Investigations focus on molecular mechanisms and assay readouts only.
For laboratory research only. Not for human use.

Key features

• ACTH(4–10)-derived peptide analogue for in-vitro signalling and SAR studies.
• Supplied as a lyophilised solid for straightforward handling and storage.
• Unit size: 10 mg per vial.
• Each batch released after stringent internal quality checks.

Specifications for Semax

• Product name: Semax
• Synonyms: ACTH(4–10) analogue; MEHFPGP peptide
• Sequence (one-letter): M-E-H-F-P-G-P
• Class: Neuropeptide analogue (research use)
• Form: Lyophilised powder
• Appearance: White to off-white solid
• Note: Counter-ion/hydration state may vary. Refer to the vial label for lot-specific details.

Handling & storage

1. Storage (dry): Keep vials at 2–8 °C, protected from light and moisture.
2. Reconstitution: For step-by-step guidance, see our internal guide:
   Reconstituting & Storage.
3. After reconstitution: Store at 2–8 °C, protect from light, use aliquots to reduce handling, and avoid repeated temperature cycling.
4. Compatibility: Use only within research protocols that follow your lab’s SOPs and local regulations.

Looking for complementary materials? See
Bacteriostatic Water 10 ml and related neuropeptides such as
Selank 10 mg and
DSIP 10 mg.

About Semax in research

Researchers use Semax in model systems to examine peptide-mediated signalling relevant to neuronal and cellular pathways, to profile downstream assay responses, and to compare structure–activity relationships—exclusively in controlled, non-clinical in-vitro environments.